Suchergebnisse - "Chen, Lindi"

PubPharm (20)

1

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Tucker, E. | Jiménez, I. | Chen, L. | +32

2

COMBINATION THERAPIES TARGETING ALK-ABERRANT NEUROBLASTOMA IN PRECLINICAL MODELS

enthalten in: bioRxiv.org | 2022

von Tucker, E. | Jiménez, I. | Chen, L. | +32

3

Increased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma Cells

enthalten in: Cancers | 2021

von King, D. | Southgate, H. | Roetschke, S. | +10

4

ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms

enthalten in: Cancers | 2020

von Southgate, H. | Chen, L. | Tweddle, D. | +1

5

Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma

enthalten in: Frontiers in oncology | 2020

von Southgate, H. | Chen, L. | Curtin, N. | +1

6

Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Merugu, S. | Chen, L. | Gavens, E. | +13

7

Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma

enthalten in: International journal of cancer | 2019

von Chen, L. | Pastorino, F. | Berry, P. | +11

8

Assessment of sleep quality using cardiopulmonary coupling analysis in patients with Parkinson's disease

enthalten in: Brain and behavior | 2018

von Chen, L. | Liu, C. | Ye, Z. | +2

9

Characterisation of the p53 pathway in cell lines established from TH-MYCN transgenic mouse tumours

enthalten in: International journal of oncology | 2018

von Chen, L. | Esfandiari, A. | Reaves, W. | +4

10

Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse

enthalten in: Oncotarget | 2016

von Chen, L. | Humphreys, A. | Turnbull, L. | +6